Riktkurs.nu
EN | SV
CalliditasMid CapCellavision
Stockholm Stock Exchange | Mid Cap
Camurus
+25.93%
Latest
+10.86%
3 months
SEBNordea MarketsDNB MarketsDNBBryan GarnierCarnegieJefferiesPareto SecuritiesHandelsbanken Capital MarketsJefferies InternationalHandelsbanken

Price Targets For Camurus

AnalystPrice TargetDateUpside
SEB850 SEKJul 17
+25.93%
Nordea Markets733 SEKJul 17
DNB Markets750 SEKJul 17
DNB750 SEKJul 17
Bryan Garnier770 SEKJul 17
Carnegie675 SEKJul 12
Jefferies710 SEKJul 9
Pareto Securities636 SEKFeb 16
Handelsbanken Capital Markets480 SEKJan 19
Jefferies International690 SEKJan 18
Handelsbanken235 SEKDec -21

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia

The information on Riktkurs.nu is for general information purposes only. Riktkurs.nu makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to Riktkurs.nu or the information, products, services, or related information on Riktkurs.nu for any purpose. The recipient is recommended to complete his or her decision basis with the material deemed necessary. We reserve us for all types of errors as well as any malfunctions of the website. The information on Riktkurs.nu should not be seen as a recommendation to buy or sell a security.
© Riktkurs.nu 2024
Updated 7/26/2024 10:10:40 AM